drugset / Trial / NCT01146197
Input of the Use of Indometacin in Gitelman Syndrome as Compared to Potassium Sparing Diuretics
RandomizedCrossoverOpen-labelTreatment
Summary
Gitelman syndrome is a rare renal disease where the kidneys are unable to normally retain some salts (sodium, potassium and magnesium). Main consequences of these renal leaks of salts are a tendency toward low blood pressure, hypokalemia and hypomagnesemia both contributing to cardiac and muscles symptoms.
Timeline
- Start
- 2010-02
- Primary completion
- 2012-12
- Completion
- 2013-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Amiloride | Small molecule | 10 mg | — |
| Subject | Amiloride | Small molecule | 20 mg | — |
| Subject | Eplerenone | Unknown | 50 mg | — |
| Subject | Eplerenone | Unknown | 150 mg | — |
| Subject | Indomethacin | Small molecule | 75 mg | — |
| Background | Magnesium Sulfate | Other / unclassified | — | Oral |
| Background | Omeprazole | Other / unclassified | — | — |
| Background | potassium | Small molecule | — | Oral |